Clinical Trials Browser

Phase 2 × Pneumococcal Vaccines × Plasma cell × Clear all

NCT03376477 2025-08-27

Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission

Phase 2 Terminated

24 enrolled 8 charts

Multiple Myeloma

NCT00445484 2015-08-24

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

22 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell